251 related articles for article (PubMed ID: 18063543)
1. Multiple myeloma and treatment-related thromboembolism: oncology nurses' role in prevention, assessment, and diagnosis.
Wiley KE
Clin J Oncol Nurs; 2007 Dec; 11(6):847-51. PubMed ID: 18063543
[TBL] [Abstract][Full Text] [Related]
2. Lenalidomide: a new agent for patients with relapsed or refractory multiple myeloma.
Tariman JD
Clin J Oncol Nurs; 2007 Aug; 11(4):569-74. PubMed ID: 17723971
[TBL] [Abstract][Full Text] [Related]
3. Advances in oral therapy in the treatment of multiple myeloma.
Doss DS
Clin J Oncol Nurs; 2006 Aug; 10(4):514-20. PubMed ID: 16927905
[TBL] [Abstract][Full Text] [Related]
4. Clinical updates and nursing considerations for patients with multiple myeloma.
Faiman B
Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
[TBL] [Abstract][Full Text] [Related]
5. Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.
Klein U; Kosely F; Hillengass J; Hundemer M; Schmitt S; Neben K; Moehler T; Hegenbart U; Ho AD; Goldschmidt H
Ann Hematol; 2009 Jan; 88(1):67-71. PubMed ID: 18668241
[TBL] [Abstract][Full Text] [Related]
6. Lenalidomide and its role in the management of multiple myeloma.
Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma patient care: treatment options and nursing considerations.
McGee L
ONS Connect; 2007; 22(8 Suppl):67-8. PubMed ID: 17824572
[No Abstract] [Full Text] [Related]
8. Managing patients with multiple myeloma and mantle cell lymphoma: where are we now?
Amen K
ONS Connect; 2007; 22(8 Suppl):63-4. PubMed ID: 17824570
[No Abstract] [Full Text] [Related]
9. Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature.
Martin MG; Vij R
Clin Lymphoma Myeloma; 2009 Aug; 9(4):320-3. PubMed ID: 19717384
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic events associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
Rome S; Doss D; Miller K; Westphal J;
Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):21-8. PubMed ID: 18490254
[TBL] [Abstract][Full Text] [Related]
12. Lenalidomide in multiple myeloma.
Thomas SK; Richards TA; Weber DM
Best Pract Res Clin Haematol; 2007 Dec; 20(4):717-35. PubMed ID: 18070715
[TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment of MDS, multiple myeloma, and CLL.
Snively A
ONS Connect; 2007; 22(8 Suppl):55-6. PubMed ID: 17824566
[No Abstract] [Full Text] [Related]
14. Thromboembolism in patients on thalidomide for myeloma.
Bowcock SJ; Rassam SM; Ward SM; Turner JT; Laffan M
Hematology; 2002 Feb; 7(1):51-3. PubMed ID: 12171777
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide and lenalidomide in the treatment of multiple myeloma.
Kumar S; Rajkumar SV
Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621
[TBL] [Abstract][Full Text] [Related]
16. Lenalidomide: new drug. Myeloma: many questions remain unanswered.
Prescrire Int; 2008 Dec; 17(98):230-2. PubMed ID: 19422142
[TBL] [Abstract][Full Text] [Related]
17. Management of novel therapeutics' side effects: a nurse-centric model.
Davies MJ
ONS Connect; 2007; 22(8 Suppl):25-6. PubMed ID: 17824551
[No Abstract] [Full Text] [Related]
18. Cardiovascular toxicity associated with cancer treatment.
Viale PH; Yamamoto DS
Clin J Oncol Nurs; 2008 Aug; 12(4):627-38. PubMed ID: 18676329
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide in the treatment of multiple myeloma.
Kastritis E; Dimopoulos MA
Best Pract Res Clin Haematol; 2007 Dec; 20(4):681-99. PubMed ID: 18070713
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates.
Gieseler F
Thromb Haemost; 2008 Jun; 99(6):1001-7. PubMed ID: 18521500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
